Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections

Table 4 Cost results (USD 2015)

	Ceftolozane/tazobactam	Piperacillin/tazobactam	Incremental Ceftolozane/tazobactam - Piperacillin/tazobactam
Hospital costs per patient	$6996	$7429	-$433
Drug costs per patient	$766	$155	$612
Lifetime health care expenditure per patient	$28,651	$28,444	$207

ISSN: 1471-2334